Mark R. Davies

Global dissemination of a multidrug resistant <i>Escherichia coli</i> clone

Nicola K. Petty, Nouri L. Ben Zakour, Mitchell Stanton‐Cook et al. · Proceedings of the National Academy of Sciences · 2014 · 545 citations · Full text

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline

Violette Da Cunha, Mark R. Davies, Pierre-Emmanuel Douarre et al. · Nature Communications · 2014 · 240 citations · Full text

Sequence element enrichment analysis to determine the genetic basis of bacterial phenotypes

John A. Lees, Minna Vehkala, Niko Välimäki et al. · Nature Communications · 2016 · 220 citations · Full text

Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics

Mark R. Davies, Liam McIntyre, Ankur Mutreja et al. · Nature Genetics · 2019 · 198 citations · Full text

Vaccination, Reverse Vaccinology, Vaccine Target +8

Protection against Group A Streptococcus by Immunization with J8–Diphtheria Toxoid: Contribution of J8‐ and Diphtheria Toxoid–Specific Antibodies to Protection

Michael R. Batzloff, Wendy A. Hayman, Mark R. Davies et al. · The Journal of Infectious Diseases · 2003 · 192 citations · Full text